PSYCH up2date, Table of Contents PSYCH up2date 2019; 13(03): 243-260DOI: 10.1055/a-0646-9925 Angststörungen, Zwangsstörungen und stressassoziierte Störungen Die generalisierte Angststörung – ein Update Authors Jens Plag Jürgen Hoyer Recommend Article Abstract Buy Article(opens in new window) All articles of this category(opens in new window) Update of:Generalisierte AngststörungPSYCH up2date 2013; 7(02): 89-104DOI: 10.1055/s-0032-1332872 Sorgen und Befürchtungen sind das zentrale Element der generalisierten Angststörung (GAS). Die GAS wird in der ICD-11 deutliche konzeptionelle Veränderungen erfahren, die insbesondere der voranschreitenden klinischen und epidemiologischen Forschung Rechnung tragen. Der folgende Artikel stellt ein „Update“ unseres Beitrags aus dem Jahr 2013 dar mit Ergänzungen um aktuelle Befunde und Entwicklungen. Schlüsselwörter SchlüsselwörterGeneralisierte Angststörung - Psychotherapie - Pharmakotherapie - Neurobiologie Full Text References Literatur 1 Beard GM. A Practical Treatise on nervous Exhaustion (Neurasthenia). New York, NY: William Wood; 1880 2 Freud S. Über die Berechtigung, von der Neurasthenie einen bestimmten Symptomenkomplex als „Angstneurose“ abzutrennen. Internationale Zeitschrift für Ärztliche Psychoanalyse 1913; 1: 359-362 3 Crocq MA. The history of generalized anxiety disorder as a diagnostic category. Dialogues Clin Neurosci 2017; 19: 107-116 4 World Health Organisation (WHO). The 11th Revision of the International Classification of Diseases (ICD-11) – Generalized Anxiety Disorder. Im Internet: Accessed December 19, 2018 at: https://icd.who.int/dev11/f/en%23/http%253a%252f%252fid.who.int%252ficd%252fentity%252f1712535455 5 American Psychiatric Association. Diagnostic and statistical Manual of mental Disorders. 5th ed. Washington, DC: APA; 2013 6 Hoyer J, Becker ES, Roth WT. Characteristics of worry in GAD patients, social phobics, and controls. Depress Anxiety 2001; 13: 89-96 7 Becker E, Margraf J. Generalisierte Angststörung. Ein Therapieprogramm. Weinheim: Beltz; 2007 8 Becker ES, Hoyer J. Generalisierte Angststörung. Göttingen: Hogrefe; 2005 9 Jacobi F, Höfler M, Siegert J. et al. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res 2014; 23: 304-319 10 Altunoz U, Kokurcan A, Kirici S. et al. Clinical characteristics of generalized anxiety disorder: older vs. young adults. Nord J Psychiatry 2018; 72: 97-102 11 Nilsson J, Sigström R, Östling S. et al. Changes in the expression of worries, anxiety, and generalized anxiety disorder with increasing age: A population study of 70 to 85-year-olds. Int J Geriatr Psychiatry 2018; 12 Wittchen HU. Generalized anxiety disorder: Prevalence, burden, and cost to society. Depress Anxiety 2002; 16: 162-171 13 Friborg O, Martinussen M, Kaiser S. et al. Comorbidity of personality disorders in anxiety disorders: a meta-analysis of 30 years of research. J Affect Disord 2013; 145: 143-155 14 Goldstein-Piekarski AN, Williams LM, Humphreys K. A trans-diagnostic review of anxiety disorder comorbidity and the impact of multiple exclusion criteria on studying clinical outcomes in anxiety disorders. Transl Psychiatry 2016; 6: e847 15 Tully PJ, Cosh SM. Generalized anxiety disorder prevalence and comorbidity with depression in coronary heart disease: a meta-analysis. J Health Psychol 2013; 18: 1601-1616 16 Bandelow B. Generalized Anxiety Disorder and Pain. Mod Trends Pharmacopsychiatry 2015; 30: 153-165 17 Csupak B, Sommer JL, Jacobsohn E. et al. A population-based examination of the co-occurrence and functional correlates of chronic pain and generalized anxiety disorder. J Anxiety Disord 2018; 56: 74-80 18 Toghanian S, Dibonaventura M, Järbrink K. et al. Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe. Clinicoecon Outcomes Res 2014; 6: 151-163 19 Moon CM, Jeong GW. Alterations in white matter volume and its correlation with clinical characteristics in patients with generalized anxiety disorder. Neuroradiology 2015; 57: 1127-1134 20 Moon CM, Jeong GW. Abnormalities in gray and white matter volumes associated with explicit memory dysfunction in patients with generalized anxiety disorder. Acta Radiol 2017; 58: 353-361 21 Kim GW, Yoon W, Jeong GW. Whole-brain volume alteration and its correlation with anxiety severity in patients with obsessive-compulsive disorder and generalized anxiety disorder. Clin Imaging 2018; 50: 164-170 22 Fonzo GA, Etkin A. Affective neuroimaging in generalized anxiety disorder: an integrated review. Dialogues Clin Neurosci 2017; 19: 169-179 23 Nitschke JB, Saarinopoulos I, Oathes DJ. et al. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry 2009; 166: 302-310 24 Plag J, Ströhle A. Angststörungen: Neurobiologie. In: Gründer G, Benkert O. Hrsg. Handbuch der psychiatrischen Pharmakotherapie. 2. Aufl.. Heidelberg: Springer; 2012 25 Blair KS, Geraci M, Smith BW. et al. Reduced dorsal anterior cingulate cortical activity during emotional regulation and top-down attentional control in generalized social phobia, generalized anxiety disorder, and comorbid generalized social phobia/generalized anxiety disorder. Biol Psychiatry 2012; 72: 476-482 26 Ball TM, Ramsawh HJ, Campbell-Sills L. et al. Prefrontal dysfunction during emotion regulation in generalized anxiety and panic disorders. Psychol Med 2013; 43: 1475-1486 27 Krain AL, Gotimer K, Hefton S. et al. A functional magnetic resonance imaging investigation of uncertainty in adolescents with anxiety disorders. Biol Psychiatry 2008; 63: 563-568 28 Hettema JM, Prescott CA, Kendler KS. A population-based twin study of generalized anxiety disorder in men and women. J Nerval Ment Dis 2001; 189: 413-420 29 Mackintosh MA, Gatz M, Loebach Wetherell J. et al. A twin study of lifetime generalized anxiety disorder (GAD) in older adults: Genetic and environmental influences shared by neuroticism and GAD. Twin Res Human Genetics 2008; 9: 30-37 30 Dellava JE, Kendler KS, Neale MC. Generalized anxiety disorder and anorexia nervosa: evidence of shared genetic variation. Depress Anxiety 2011; 28: 728-733 31 Gottschalk MG, Domschke K. Genetics of generalized anxiety disorder and related traits. Dialogues Clin Neurosci 2017; 19: 159-168 32 Vreeburg SA, Zitman FG, van Pelt J. et al. Salivary cortisol levels in persons with and without different anxiety disorders. Psychosom Med 2010; 72: 340-347 33 Plag J, Schumacher S, Schmid U. et al. Baseline and acute changes in the HPA system in patients with anxiety disorders: the current state of research. Neuropsychiatry (London) 2013; 3: 45-62 34 Brosschot JF, Van Dijk E, Thayer JF. Daily worry is related to low heart rate variability during waking and the subsequent nocturnal sleep period. Int J Psychophysiol 2007; 63: 39-47 35 Chalmers JA, Quintana DS, Abbott MJ. et al. Anxiety Disorders are associated with reduced heart rate variability: a meta-analysis. Front Psychiatry 2014; 5: 80 36 Borkovec TD, Alcaine OM, Behar E. Avoidance Theory of Worry and generalized Anxiety Disorder. In: Heimberg RG, Turk CL, Mennin DS. eds. Generalized Anxiety Disorder: Advances in Research and Practice. New York: Guilford Press; 2004 37 Newman MC, Llera SL. A novel theory of experiential avoidance in generalized anxiety disorder: A review and synthesis of research supporting a contrast avoidance model of worry. Clin Psychol Rev 2011; 38 Bandelow B, Wiltink J, Alpers GW. et al. Deutsche S3-Leitlinie Behandlung von Angststörungen (2014). Im Internet: Accessed December 19, 2018 at: https://www.awmf.org/leitlinien/detail/ll/051-028.html 39 Newman M, Zainal H, Hoyer J. Cognitive-behavioral treatment for GAD. In: Gerlach A, Gloster AT. The Wiley Handbook of Generalized Anxiety Disorder. Chichester: Wiley; (in press) 40 Dugas MJ, Robichaud M. Cognitive-behavioral Treatment for generalized Anxiety Disorder. New York: Routledge; 2007 41 Longmore RJ, Worrell M. Do we need to challenge thoughts in cognitive behavior therapy?. Clin Psychol Rev 2007; 27: 173-187 42 Foa EB, Kozak M. Emotional processing of fear: Exposure to corrective information. Psychol Bull 1986; 99: 20-35 43 Wells A. Metakognitive Therapie bei Angststörungen und Depression. Weinheim: Beltz; 2011 44 Hoyer J, Beesdo-Baum K. Prolonged imaginal Exposure based on Worry Scenarios. In: Neudeck P, Wittchen HU. eds. Exposure Therapy: Rethinking the Model – Refining the Method. New York: Springer; 2012: 245-260 45 Hoyer J, Beesdo K, Becker ES. Patientenratgeber Generalisierte Angststörung. Göttingen: Hogrefe; 2007 46 Hoyer J, Gloster AT. Psychotherapy for generalized anxiety disorder: Donʼt worry, it works!. Psychiatr Clin North Am 2009; 32: 629-640 47 Hunot V, Churchill R, Silva de Lima M. et al. Psychological therapies for generalised anxiety disorder. Cochrane Database Syst Rev 2007; (01) CD001848 48 Cuijpers P, Gentili C, Banos RM. et al. Relative effects of cognitive and behavioral therapies on generalized anxiety disorder, social anxiety disorder and panic disorder: A meta-analysis. J Anxiety Disord 2016; 43: 79-89 49 Van der Heiden C, Muris P, Van der Molen HT. Randomized controlled trial on the effectiveness of metacognitive therapy and tolerance-of-uncertainty therapy for generalized anxiety disorder. Behav Res Ther 2012; 50: 100-109 50 Nordahl HM, Borkovec TD, Hagen R. et al. Metacognitive therapy versus cognitive-behavioural therapy in adults with generalised anxiety disorder. B J Psych Open 2018; 4: 393-400 51 Andersson E, Hedman E, Wadström O. et al. Internet-based extinction therapy for worry: a randomized controlled trial. Behav Ther 2017; 48: 391-402 52 Hayes-Skelton SA, Roemer L, Orsillo SM. A randomized clinical trial comparing an acceptance-based behavior therapy to applied relaxation for generalized anxiety disorder. J Consult Clin Psychol 2013; 81: 761-773 53 Leichsenring F, Salzer S, Jaeger U. et al. Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: A randomized, controlled trial. Am J Psychiatry 2009; 166: 875-881 54 Leichsenring F, Winkelbach C, Leibing E. Psychoanalytisch-orientierte Fokaltherapie der generalisierten Angststörung. Ein Manual. Psychotherapeut 2005; 50: 258-264 55 Vøllestad J, Sivertsen B, Nielsen GH. Mindfulness-based stress reduction for patients with anxiety disorders: evaluation in a randomized controlled trial. Behav Res Ther 2011; 49: 281-288 56 Westra HA, Constantino MJ, Antony MM. Integrating motivational interviewing with cognitive-behavioral therapy for severe generalized anxiety disorder: An allegiance-controlled randomized clinical trial. J Consult Clin Psychol 2016; 84: 768-782 57 Constantino MJ, Westra HA, Antony MM. et al. Specific and common processes as mediators of the long-term effects of cognitive-behavioral therapy integrated with motivational interviewing for generalized anxiety disorder. Psychother Res 2017; 5: 1-13 58 Boettcher J, Aström V, Påhlsson D. et al. Internet-based mindfulness treatment for anxiety disorders: a randomized controlled trial. Behav Ther 2014; 45: 241-253 59 Dahlin M, Andersson G, Magnusson K. et al. Internet-delivered acceptance-based behaviour therapy for generalized anxiety disorder: A randomized controlled trial. Behav Res Ther 2016; 77: 86-95 60 Maneeton N, Maneeton B, Woottiluk P. et al. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther 2016; 10: 259-276 61 Albert U, Carmassi C, Cosci F. et al. Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders: a systematized review. Int Clin Psychopharmacol 2016; 31: 249-258 62 Plag J, Ströhle A. Angststörungen: Klinische Pharmakotherapie. In: Gründer G, Benkert O. Hrsg. Handbuch der psychiatrischen Pharmakotherapie. 2. Aufl.. Heidelberg: Springer; 2012: 1005-1019 63 Álvarez E, Olivares JM, Carrasco JL. et al. Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors. Ann Gen Psychiatry 2015; 14: 2 64 Crits-Christoph P, Newman MG, Rickels K. et al. Combined medication and cognitive therapy for generalized anxiety disorder. J Anxiety Disord 2011; 25: 1087-1094 65 Beesdo-Baum K, Jenjahn E, Höfler M. et al. Avoidance, safety behavior, and reassurance seeking in generalized anxiety disorder. Depress Anxiety 2012; 29: 948-957 66 Kasper S, Möller HJ, Volz HP. et al. Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set. Int Clin Psychopharmacol 2017; 32: 195-204 67 Ooi SL, Henderson P, Pak SC. Kava for Generalized Anxiety Disorder: A review of current evidence. J Altern Complement Med 2018; 24: 770-780 68 Gabriel MG, Curtiss J, Hofmann SG. et al. Kundalini Yoga for Generalized Anxiety Disorder: An exploration of treatment efficacy and possible mechanisms. Int J Yoga Therap 2018; 28: 97-105 69 Hoyer J, Köllner V. Pflanzliche Mittel bei Angststörungen. Eine wirksame und nebenwirkungsarme Ergänzung zur Psychotherapie?. Psychotherapie im Dialog 2015; 16: 56-59 70 Kozel FA. Clinical repetitive transcranial magnetic stimulation for posttraumatic stress disorder, generalized anxiety disorder, and bipolar disorder. Psychiatr Clin North Am 2018; 41: 433-446 71 Mergl R, Henkel V, Allgaier AK. et al. Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patientsʼ choice arm. Psychother Psychosom 2011; 80: 39-47
